Skip to main content
Erschienen in: Journal of Cancer Education 2/2012

01.06.2012

Effect of Comorbid Conditions on Adherence to Colorectal Cancer Screening

verfasst von: Dana J. Lukin, Lina H. Jandorf, Rayhana J. Dhulkifl, Linda D. Thélémaque, Jennifer A. Christie, Steven H. Itzkowitz, Katherine N. DuHamel

Erschienen in: Journal of Cancer Education | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Potential barriers to colorectal cancer (CRC) screening include preexisting medical conditions (comorbidities), physician recommendation, psychosocial factors, and screening preparedness. This study's purpose was to investigate the impact of comorbid conditions on CRC screening among African Americans. A stage-matched randomized clinical trial was performed. Asymptomatic African Americans over age 50, with a primary care physician, and eligible for CRC screening were recruited at The Mount Sinai Hospital from 2005 to 2008. One hundred sixty-one patients were assessed for referral for, and completion of, CRC screening, comorbid conditions, “readiness to change,” and number of physician visits within the observation period. Data was compared to a pretrial index to predict the likely effect of comorbid conditions on CRC screening. One hundred fifty-nine patients completed the study; 108 (68.9%) were referred for and 34 (21.2%) completed CRC screening. No demographic characteristics were associated with CRC screening completion. CRC screening referrals were similar for all patients, regardless of comorbidities or clinical visits. Comorbidities rated as having extreme influence on CRC screening showed a trend toward lower screening rates. There was a significant increase in screening rates among participants in advanced stages of readiness at enrollment. These data suggest that while comorbidities did not predict colonoscopy completion, they may play a role in concert with other factors. This is the only study to assess the effect of screening colonoscopy in an African American primary care setting. We must continue to explore interventions to narrow the disparate gap in screening and mortality rates.
Literatur
1.
2.
Zurück zum Zitat Beydoun HA, Beydoun MA (2008) Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 19(4):339–359PubMedCrossRef Beydoun HA, Beydoun MA (2008) Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 19(4):339–359PubMedCrossRef
4.
Zurück zum Zitat U.S. Centers for Disease Control (2001) Trends in screening for colorectal cancer - United States, 1997 and 1998. MMWR 50(9): 167–168 U.S. Centers for Disease Control (2001) Trends in screening for colorectal cancer - United States, 1997 and 1998. MMWR 50(9): 167–168
5.
Zurück zum Zitat Polite BN, Dignam JJ, Olopade OI (2006) Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24(14):2179–2187PubMedCrossRef Polite BN, Dignam JJ, Olopade OI (2006) Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24(14):2179–2187PubMedCrossRef
6.
Zurück zum Zitat Subramanian S, Amonkar MM, Hunt TL (2005) Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 14(2):409–416PubMedCrossRef Subramanian S, Amonkar MM, Hunt TL (2005) Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 14(2):409–416PubMedCrossRef
7.
Zurück zum Zitat Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007) Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev 16(3):494–499PubMedCrossRef Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M (2007) Potential for colorectal cancer prevention of sigmoidoscopy versus colonoscopy: population-based case control study. Cancer Epidemiol Biomarkers Prev 16(3):494–499PubMedCrossRef
8.
Zurück zum Zitat Lieberman D (2006) Screening for colorectal cancer in average-risk populations. Am J Med 119(9):728–735PubMedCrossRef Lieberman D (2006) Screening for colorectal cancer in average-risk populations. Am J Med 119(9):728–735PubMedCrossRef
9.
Zurück zum Zitat Chen LA, Santos S, Jandorf L, Christie J, Castillo A, Winkel G et al (2008) A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol 6(4):443–450PubMedCrossRef Chen LA, Santos S, Jandorf L, Christie J, Castillo A, Winkel G et al (2008) A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol 6(4):443–450PubMedCrossRef
10.
Zurück zum Zitat Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422PubMedCrossRef Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422PubMedCrossRef
11.
Zurück zum Zitat Basch CE, Wolf RL, Brouse CH, Shmukler C, Neugut A, DeCarlo LI et al (2006) Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health 96(12):2246–2253PubMedCrossRef Basch CE, Wolf RL, Brouse CH, Shmukler C, Neugut A, DeCarlo LI et al (2006) Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health 96(12):2246–2253PubMedCrossRef
12.
Zurück zum Zitat Levin B, Lieberman DA, Mcfarland B, Andrews KS, Brooks D, Bond J et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595PubMedCrossRef Levin B, Lieberman DA, Mcfarland B, Andrews KS, Brooks D, Bond J et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595PubMedCrossRef
13.
Zurück zum Zitat Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS et al (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328(13):901–906PubMedCrossRef Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS et al (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328(13):901–906PubMedCrossRef
14.
Zurück zum Zitat Winawer SJ, Zauber AG, Stewart ET, O'Brien MJ (1991) The natural history of colorectal cancer: opportunities for intervention. Cancer 67:1143–1149PubMedCrossRef Winawer SJ, Zauber AG, Stewart ET, O'Brien MJ (1991) The natural history of colorectal cancer: opportunities for intervention. Cancer 67:1143–1149PubMedCrossRef
15.
Zurück zum Zitat Bertakis KD, Roter D, Putnam SM (1991) The relationship of physician medical interview style to patient satisfaction. J Fam Pract 32(2):175–181PubMed Bertakis KD, Roter D, Putnam SM (1991) The relationship of physician medical interview style to patient satisfaction. J Fam Pract 32(2):175–181PubMed
17.
Zurück zum Zitat Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345(8):555–560PubMedCrossRef Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345(8):555–560PubMedCrossRef
18.
Zurück zum Zitat Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343(3):169–174PubMedCrossRef Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343(3):169–174PubMedCrossRef
19.
Zurück zum Zitat Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, Kikendall JW, Kim HM, Weiss DG, Emory T, Schatzkin A, Lieberman D (2005) Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352(20):2061–2068PubMedCrossRef Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, Kikendall JW, Kim HM, Weiss DG, Emory T, Schatzkin A, Lieberman D (2005) Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352(20):2061–2068PubMedCrossRef
20.
21.
Zurück zum Zitat Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD et al (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359(12):1207–1217PubMedCrossRef Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD et al (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359(12):1207–1217PubMedCrossRef
23.
Zurück zum Zitat Jerant AF, Fenton JJ, Franks P (2008) Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 168(12):1317–1324PubMedCrossRef Jerant AF, Fenton JJ, Franks P (2008) Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 168(12):1317–1324PubMedCrossRef
24.
Zurück zum Zitat Christie J, Nassisi D, Wilets I, DuHamel KN, Winkel G, Hilliard R et al (2006) Assessing endoscopic colorectal screening adherence in an emergency department population. J Natl Med Assoc 98(7):1095–1101PubMed Christie J, Nassisi D, Wilets I, DuHamel KN, Winkel G, Hilliard R et al (2006) Assessing endoscopic colorectal screening adherence in an emergency department population. J Natl Med Assoc 98(7):1095–1101PubMed
25.
Zurück zum Zitat Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3–15PubMedCrossRef Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3–15PubMedCrossRef
26.
Zurück zum Zitat Christie J, Jandorf L, Itzkowitz S, Halm E, Freeman K, King S et al (2009) Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethnic Dis Summer 19(3):323–329 Christie J, Jandorf L, Itzkowitz S, Halm E, Freeman K, King S et al (2009) Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethnic Dis Summer 19(3):323–329
27.
Zurück zum Zitat Ford ME, Havstad SL, Fields ME, Manigo B, McClary B, Lamerato L (2008) Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Cancer Epidemiol Biomarkers Prev 17(5):1234–1239PubMedCrossRef Ford ME, Havstad SL, Fields ME, Manigo B, McClary B, Lamerato L (2008) Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Cancer Epidemiol Biomarkers Prev 17(5):1234–1239PubMedCrossRef
28.
Zurück zum Zitat Walter LC, Lindquist K, Covinsky KE (2004) Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med 140(9):681–688PubMed Walter LC, Lindquist K, Covinsky KE (2004) Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med 140(9):681–688PubMed
29.
Zurück zum Zitat Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50(10):1651–1658PubMedCrossRef Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50(10):1651–1658PubMedCrossRef
30.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
Metadaten
Titel
Effect of Comorbid Conditions on Adherence to Colorectal Cancer Screening
verfasst von
Dana J. Lukin
Lina H. Jandorf
Rayhana J. Dhulkifl
Linda D. Thélémaque
Jennifer A. Christie
Steven H. Itzkowitz
Katherine N. DuHamel
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 2/2012
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0303-2

Weitere Artikel der Ausgabe 2/2012

Journal of Cancer Education 2/2012 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.